Two photoactive Ru (II) compounds based on tetrazole ligands for photodynamic therapy

被引:14
作者
Yang, Jie [1 ,2 ]
He, Xin [3 ]
Ke, Zhen [1 ]
Chen, Jianjiao [1 ]
Zou, Zhenyuan [1 ]
Wei, Bo [2 ]
Zou, Dengfeng [1 ]
Zou, Jianhua [2 ]
机构
[1] Guilin Med Univ, Sch Pharm, Guilin 541004, Guangxi, Peoples R China
[2] Changshu Inst Technol, Dept Chem & Mat Engn, Jiangsu Key Lab Adv Funct Mat, Changshu 215500, Jiangsu, Peoples R China
[3] Nanjing Tech Univ, Coll Chem Engn, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Peoples R China
关键词
Ru(II); Tetrazole; HeLa; Photodynamic therapy; COMPLEXES; LIGHT;
D O I
10.1016/j.jinorgbio.2020.111127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ru (II) compounds have potential application in photodynamic therapy (PDT). In the current study, two Ru (II) compounds based on the auxiliary ligand 2,2 '-bipyridine (bipy) by changing main ligands 5-(2-pyridyl) tetrazole (Hpytz) and di(2H-tetrazol-5-yl) amine (H(2)datz) have been successfully synthesized and characterized, [Ru (pytz)(bipy)(2)][PF6] (1) and [Ru(Hdatz)(bipy)(2)][PF6] (2). These compounds can form nanoparticles (NPs) by nano-precipitation. And [Ru(pytz)(bipy)(2)][PF6] NPs with a lower half maximal inhibitory concentration (IC50) of 37 mu g/mL on HeLa cells than that of [Ru(Hdatz)(bipy)(2)][PF6] NPs (65 mu g/mL). Meanwhile, negligible dark toxicity has been also observed for these NPs even under high concentrations. The results show that [Ru(pytz) (bipy)(2)][PF6] (1) and [Ru(Hdatz)(bipy)(2)][PF6] (2) NPs can inhibit cell proliferation in vitro, and may be potential candidates for photodynamic therapy.
引用
收藏
页数:7
相关论文
共 35 条
[11]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66
[12]   BODIPY dyes in photodynamic therapy [J].
Kamkaew, Anyanee ;
Lim, Siang Hui ;
Lee, Hong Boon ;
Kiew, Lik Voon ;
Chung, Lip Yong ;
Burgess, Kevin .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (01) :77-88
[13]   One-Step Formulation of Targeted Aggregation-Induced Emission Dots for Image-Guided Photodynamic Therapy of Cholangiocarcinoma [J].
Li, Min ;
Gao, Yang ;
Yuan, Youyong ;
Wu, Yuzhe ;
Song, Zifang ;
Tang, Ben Zhong ;
Liu, Bin ;
Zheng, Qi Chang .
ACS NANO, 2017, 11 (04) :3922-3932
[14]   Novel 3-D PtS-like tetrazolate-bridged manganese(II) complex exhibiting spin-canted antiferromagnetism and field-induced spin-flop transition [J].
Lu, Ying-Bing ;
Wang, Ming-Sheng ;
Zhou, Wei-Wei ;
Xu, Gang ;
Guo, Guo-Cong ;
Huang, Jin-Shun .
INORGANIC CHEMISTRY, 2008, 47 (19) :8935-8942
[15]   Transition-Metal-Free CO-Releasing BODIPY Derivatives Activatable by Visible to NIR Light as Promising Bioactive Molecules [J].
Palao, Eduardo ;
Slanina, Tomas ;
Muchova, Lucie ;
Solomek, Tomas ;
Vitek, Libor ;
Klan, Petr .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (01) :126-133
[16]   Heavy atom-free semiconducting polymer with high singlet oxygen quantum yield for prostate cancer synergistic phototherapy [J].
Shen, Jian ;
Chen, Jianjiao ;
Ke, Zhen ;
Zou, Dengfeng ;
Sun, Liguo ;
Zou, Jianhua .
MATERIALS CHEMISTRY FRONTIERS, 2019, 3 (06) :1123-1127
[17]   Syntheses and photodynamic activity of some glucose-conjugated BODIPY dyes [J].
Shivran, Neelam ;
Tyagi, Mrityunjay ;
Mula, Soumyaditya ;
Gupta, Pooja ;
Saha, Bhaskar ;
Patro, Birija S. ;
Chattopadhyay, Subrata .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 :352-365
[18]   Polypyridyl Ruthenium(II) complexes with tetrazolate-based chelating ligands. Synthesis, reactivity, and electrochemical and photophysical properties [J].
Stagni, Stefano ;
Orselli, Enrico ;
Palazzi, Antonio ;
De Cola, Luisa ;
Zacchini, Stefano ;
Femoni, Cristina ;
Marcaccio, Massimo ;
Paolucci, Francesco ;
Zanarini, Simone .
INORGANIC CHEMISTRY, 2007, 46 (22) :9126-9138
[19]  
Sun W., 2017, ADV MAT, V29, P1603
[20]   Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go? [J].
Sun, Wen ;
Thiramanas, Raweewan ;
Slep, Leonardo D. ;
Zeng, Xiaolong ;
Mailander, Volker ;
Wu, Si .
CHEMISTRY-A EUROPEAN JOURNAL, 2017, 23 (45) :10832-10837